Theriva Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	7.53	11.61	23.18	41.79	67.33	6.23
Cash & Short-Term Investments	7.53	11.61	23.18	41.79	67.33	6.23
Cash Growth	-54.12%	-49.91%	-44.53%	-37.93%	981.18%	-58.61%
Other Receivables	1.72	3.23	1.61	-	-	-
Total Trade Receivables	1.72	3.23	1.61	-	-	-
Other Current Assets	0.65	1.44	2.61	3.73	1.53	1.71
Total Current Assets	9.9	16.28	27.4	45.52	68.86	7.93
Net Property, Plant & Equipment	1.19	1.54	2.16	1.54	1.48	0.45
Other Intangible Assets	19.61	17.36	19.56	19.15	-	-
Goodwill	-	-	5.7	5.53	-	-
Other Long-Term Assets	0.13	0.17	0.18	0.12	0.02	0.02
Total Assets	30.84	35.35	55.22	71.86	70.37	8.41
Accounts Payable	0.8	0.86	0.77	0.92	0.98	0.89
Accrued Expenses	8.43	4.51	4.51	2.9	2.45	1.79
Short-Term Debt	0.06	0.06	0.06	0.06	-	-
Current Portion of Leases	0.62	0.54	0.49	0.22	0.12	0.29
Other Current Liabilities	1.1	1.61	0.91	2.97	-	-
Total Current Liabilities	11	7.59	6.74	7.06	3.55	2.97
Long-Term Debt	1.65	0.09	0.16	0.22	-	-
Long-Term Leases	0.43	0.87	1.44	1.19	1.4	0.19
Other Long-Term Liabilities	11.01	7.74	7.18	8.83	-	-
Total Long-Term Liabilities	13.1	8.7	8.78	10.24	1.4	0.19
Total Liabilities	24.1	16.29	15.52	17.3	4.96	3.15
Preferred Stock	-	-	-	-	-	15.28
Common Stock	0.01	0	0	0.02	0.01	0.03
Treasury Stock	-0.29	-0.29	-0.29	-0.29	-	-
Additional Paid-in Capital	362.97	355.5	346.54	343.75	336.68	240.82
Accumulated Other Comprehensive Income	0.76	-1.18	0.03	-0.68	-	-
Retained Earnings	-356.71	-334.97	-309.32	-290.97	-271.28	-248.09
Total Common Shareholders' Equity	6.74	19.07	36.96	51.83	65.41	8.03
Minority Interest	-	-	2.73	2.73	-	-2.77
Shareholders' Equity	6.74	19.07	39.7	54.56	65.41	5.26
Total Liabilities & Equity	30.84	35.35	55.22	71.86	70.37	8.41
Total Debt	2.76	1.57	2.15	1.68	1.53	0.47
Net Cash (Debt)	4.77	10.04	21.02	40.11	65.8	5.75
Net Cash Growth	-52.55%	-52.22%	-47.58%	-39.05%	1043.52%	-59.83%
Net Cash Per Share	0.87	7.45	32.63	65.41	134.97	75.67
Book Value	6.74	19.07	36.96	51.83	65.41	8.03
Book Value Per Share	1.22	14.14	57.37	84.54	134.17	105.61
Tangible Book Value	-12.88	1.71	11.71	27.16	65.41	8.03
Tangible Book Value Per Share	-2.34	1.27	18.17	44.29	134.17	105.61

Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q